Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Receivables: 2016-2025

Historic Receivables for cbdMD (YCBD) over the last 8 years, with Sep 2025 value amounting to $1.0 million.

  • cbdMD's Receivables rose 5.79% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 11.96%. This contributed to the annual value of $1.0 million for FY2025, which is 5.79% up from last year.
  • As of Q3 2025, cbdMD's Receivables stood at $1.0 million, which was up 7.61% from $967,310 recorded in Q2 2025.
  • cbdMD's 5-year Receivables high stood at $2.0 million for Q1 2022, and its period low was $868,217 during Q1 2024.
  • Moreover, its 3-year median value for Receivables was $1.1 million (2025), whereas its average is $1.1 million.
  • In the last 5 years, cbdMD's Receivables spiked by 179.00% in 2021 and then slumped by 43.22% in 2023.
  • Quarterly analysis of 5 years shows cbdMD's Receivables stood at $1.1 million in 2021, then dropped by 18.95% to $898,720 in 2022, then rose by 22.64% to $1.1 million in 2023, then rose by 15.48% to $1.3 million in 2024, then climbed by 5.79% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $967,310 for Q2 2025, and $1.1 million during Q1 2025.